Product Information

METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.1870 per EA under NDC 27808030501. Its NADAC has been published 50 times since Sep 10, 2025.

FDA first approved this application on Dec 19, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metoprolol Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 50 times since Sep 10, 2025, and over the history we have for it it has risen 7.3%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.